Literature DB >> 1848296

Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.

J M Domagala1, A J Bridges, T P Culbertson, L Gambino, S E Hagen, G Karrick, K Porter, J P Sanchez, J A Sesnie, F G Spense.   

Abstract

A series of 5-amino- and 5-hydroxyquinolone antibacterials substituted at C7 with a select group of common piperazinyl and 3-aminopyrrolidinyl side chains was prepared. These 5-substituted derivatives were compared to the analogous 5-hydrogen compounds for antiinfective activity by using DNA gyrase inhibition, minimum inhibitory concentrations against a variety of bacteria, and in vivo efficacy in the mouse infection model. The influence on the structure-activity relationships of varied substituents at C8 (H, F, Cl) and N1 (ethyl, cyclopropyl, difluorophenyl) was also studied. The results showed that several of the structure-activity conclusions regarding side-chain bulk at C7, the effect of halogen at C8, and the effect of the C5-amino group were greatly influenced by the choice of the N1-substituent. Several outstanding broad spectrum quinolones were identified in this work. In particular, the spectrum and potency of the 7-piperazinyl quinolones could be greatly enhanced by the judicious choice of C5-, C8-, and N1-substituents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848296     DOI: 10.1021/jm00107a039

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Non-stochastic and stochastic linear indices of the molecular pseudograph's atom-adjacency matrix: a novel approach for computational in silico screening and "rational" selection of new lead antibacterial agents.

Authors:  Yovani Marrero-Ponce; Ricardo Medina Marrero; Francisco Torrens; Yamile Martinez; Milagros García Bernal; Vicente Romero Zaldivar; Eduardo A Castro; Ricardo Grau Abalo
Journal:  J Mol Model       Date:  2005-11-04       Impact factor: 1.810

2.  Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.

Authors:  T E Renau; J W Gage; J A Dever; G E Roland; E T Joannides; M A Shapiro; J P Sanchez; S J Gracheck; J M Domagala; M R Jacobs; R C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Anti-Mycobacterium avium activity of quinolones: in vitro activities.

Authors:  G Klopman; S Wang; M R Jacobs; S Bajaksouzian; K Edmonds; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

4.  N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.

Authors:  G Klopman; D Fercu; T E Renau; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.

Authors:  M J Robinson; B A Martin; T D Gootz; P R McGuirk; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

6.  Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.

Authors:  S H Elsea; P R McGuirk; T D Gootz; M Moynihan; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

7.  In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.

Authors:  G Klopman; J Y Li; S Wang; A J Pearson; K Chang; M R Jacobs; S Bajaksouzian; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

8.  Ciprofloxacin is an inhibitor of the Mcm2-7 replicative helicase.

Authors:  Nicholas Simon; Matthew L Bochman; Sandlin Seguin; Jeffrey L Brodsky; William L Seibel; Anthony Schwacha
Journal:  Biosci Rep       Date:  2013-10-07       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.